Q2 2014
Released Aug 13, 2014, after the close
10-Q filed Aug 13, 2014, 44 days after period end · 0001144204-14-049314
Q2 2014 · 10-Q
Revenue—
Net Income-$6.97M-$6.97M N/M vs Q2 2013N/M vs Q1 2014
EPS Diluted-$0.55-$0.55 N/M vs Q2 2013N/M vs Q1 2014
Operating Income-$7,009,562N/M
Operating Cash Flowderived-$7,646,300N/M
Free Cash Flowderived-$7,646,300N/M
What the release said
The release
Same quarter
| Metric | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|
| Net Income | -$6.97M | -$1.37M | -$61.23K |
| EPS Diluted | -$0.55 | -$0.31 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR